ATE231846T1 - Benzoxazinone als dopamine -d4- rezeptor- antagonisten - Google Patents

Benzoxazinone als dopamine -d4- rezeptor- antagonisten

Info

Publication number
ATE231846T1
ATE231846T1 AT97925651T AT97925651T ATE231846T1 AT E231846 T1 ATE231846 T1 AT E231846T1 AT 97925651 T AT97925651 T AT 97925651T AT 97925651 T AT97925651 T AT 97925651T AT E231846 T1 ATE231846 T1 AT E231846T1
Authority
AT
Austria
Prior art keywords
benzoxazinones
dopamine
receptor antagonists
antagonists
receptor
Prior art date
Application number
AT97925651T
Other languages
English (en)
Inventor
Thomas Belliotti
Lawrence David Wise
David Juergen Wustrow
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE231846T1 publication Critical patent/ATE231846T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97925651T 1996-05-29 1997-05-20 Benzoxazinone als dopamine -d4- rezeptor- antagonisten ATE231846T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1838396P 1996-05-29 1996-05-29
US4020897P 1997-03-06 1997-03-06
PCT/US1997/008524 WO1997045419A1 (en) 1996-05-29 1997-05-20 Benzoxazinone dopamine d4 receptor antagonists

Publications (1)

Publication Number Publication Date
ATE231846T1 true ATE231846T1 (de) 2003-02-15

Family

ID=26691052

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97925651T ATE231846T1 (de) 1996-05-29 1997-05-20 Benzoxazinone als dopamine -d4- rezeptor- antagonisten

Country Status (36)

Country Link
EP (1) EP0906294B1 (de)
JP (1) JP2000511534A (de)
KR (1) KR20000016151A (de)
CN (1) CN1074764C (de)
AR (1) AR008372A1 (de)
AT (1) ATE231846T1 (de)
AU (1) AU731104B2 (de)
BG (1) BG64049B1 (de)
BR (1) BR9709630A (de)
CA (1) CA2253406A1 (de)
CO (1) CO4940505A1 (de)
CZ (1) CZ384698A3 (de)
DE (1) DE69718786T2 (de)
DK (1) DK0906294T3 (de)
EA (1) EA001486B1 (de)
EE (1) EE03686B1 (de)
ES (1) ES2191180T3 (de)
GE (1) GEP20012389B (de)
HN (1) HN1997000075A (de)
HR (1) HRP970301B1 (de)
HU (1) HUP9903758A3 (de)
ID (1) ID17266A (de)
IL (1) IL126895A (de)
NO (1) NO312296B1 (de)
NZ (1) NZ332737A (de)
PA (1) PA8431101A1 (de)
PE (1) PE69398A1 (de)
PL (1) PL330195A1 (de)
PT (1) PT906294E (de)
RO (1) RO120845B1 (de)
SI (1) SI0906294T1 (de)
SK (1) SK282703B6 (de)
SV (1) SV1997000047A (de)
TW (1) TW542833B (de)
UY (1) UY24569A1 (de)
WO (1) WO1997045419A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177422B1 (en) 1996-05-29 2001-01-23 Warner-Lambert Company Benzoxazinone dopamine D4 receptor antagonists
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
US6177566B1 (en) 1998-06-30 2001-01-23 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
CA2336089A1 (en) * 1998-06-30 2000-01-06 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
US6291463B1 (en) 1998-06-30 2001-09-18 Neurogen Corporation 1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands
WO2000000482A1 (en) * 1998-06-30 2000-01-06 Neurogen Corporation 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands
DE19844291A1 (de) 1998-09-18 2000-03-23 Schering Ag Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US6939871B2 (en) * 2000-10-26 2005-09-06 Smithkline Beecham P.L.C. Benzoxazinone derivatives, their preparation and use
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
ES2232292B1 (es) * 2003-07-30 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
CN100455573C (zh) * 2005-11-11 2009-01-28 华东理工大学 一种制备1,4-苯并噁唑嗪-3-酮化合物的微波合成方法
KR200482995Y1 (ko) 2015-08-19 2017-03-23 이현진 물 공급부를 구비하는 얼음 트레이
CN116601148A (zh) * 2021-04-23 2023-08-15 上海翰森生物医药科技有限公司 杂环类衍生物抑制剂、其制备方法和应用
US20250214980A1 (en) 2022-03-14 2025-07-03 Slap Pharmaceuticals Llc Multicyclic compounds
EP4514795A4 (de) * 2022-04-28 2025-12-31 Ningbo Newbay Tech Development Co Ltd Verbindungen als parp1-hemmer
CN117903159A (zh) * 2022-12-30 2024-04-19 成都硕德药业有限公司 一种内酰胺类衍生物、其制备方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613598A (en) * 1984-03-13 1986-09-23 Mitsubishi Chemical Industries Limited Piperazine derivatives and their acid addition salts
EP0233728A1 (de) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazin-Derivate, ihre Herstellung und Verwendung
ATE171162T1 (de) * 1992-08-06 1998-10-15 Smithkline Beecham Plc 5-(2-oxyphenyl)-pyrrol-derivate als dopamin-d3- rezeptor-antagonisten

Also Published As

Publication number Publication date
KR20000016151A (ko) 2000-03-25
PA8431101A1 (es) 2001-12-14
PE69398A1 (es) 1998-12-02
SK162798A3 (en) 1999-06-11
DE69718786T2 (de) 2003-10-23
IL126895A0 (en) 1999-09-22
HK1019737A1 (en) 2000-02-25
DK0906294T3 (da) 2003-05-05
ID17266A (id) 1997-12-18
SV1997000047A (es) 1998-08-13
HRP970301A2 (en) 1998-04-30
TW542833B (en) 2003-07-21
BR9709630A (pt) 1999-08-10
JP2000511534A (ja) 2000-09-05
HN1997000075A (es) 1997-07-30
DE69718786D1 (de) 2003-03-06
AU3072797A (en) 1998-01-05
HRP970301B1 (en) 2002-08-31
GEP20012389B (en) 2001-03-25
EA199800987A1 (ru) 1999-06-24
CO4940505A1 (es) 2000-07-24
NO312296B1 (no) 2002-04-22
WO1997045419A1 (en) 1997-12-04
NZ332737A (en) 2000-06-23
NO985531D0 (no) 1998-11-27
NO985531L (no) 1998-11-27
CA2253406A1 (en) 1997-12-04
AU731104B2 (en) 2001-03-22
SI0906294T1 (en) 2003-04-30
PT906294E (pt) 2003-06-30
AR008372A1 (es) 2000-01-19
EP0906294A1 (de) 1999-04-07
PL330195A1 (en) 1999-04-26
BG64049B1 (bg) 2003-11-28
EP0906294B1 (de) 2003-01-29
IL126895A (en) 2001-06-14
HUP9903758A3 (en) 2000-07-28
HUP9903758A2 (hu) 2000-06-28
UY24569A1 (es) 2001-08-27
BG102959A (en) 1999-08-31
EE03686B1 (et) 2002-04-15
EA001486B1 (ru) 2001-04-23
CN1074764C (zh) 2001-11-14
CZ384698A3 (cs) 1999-03-17
ES2191180T3 (es) 2003-09-01
EE9800417A (et) 1999-06-15
RO120845B1 (ro) 2006-08-30
SK282703B6 (sk) 2002-11-06
CN1219930A (zh) 1999-06-16

Similar Documents

Publication Publication Date Title
NO20015899D0 (no) Benzotiazinon- og benzoksazinonforbindelser
DE69718786D1 (de) Benzoxazinone als dopamine -d4- rezeptor-antagonisten
ATE233260T1 (de) Muscarin-antagonisten
EP0986385A4 (de) Antagonisten des gonadorelins
BR9703128A (pt) Classificador com argolas
BR9703123A (pt) Classificador com argolas
BR9612532A (pt) Máquina misturadora
EP0758898A4 (de) Activinantagonisten als verhütungsmittel
EP0885205A4 (de) Fibrinogen-rezeptor-antagonisten
ATE194595T1 (de) Benzonitrile als 5-ht agonisten und antagonisten
DE69626220D1 (de) 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten
ATE221052T1 (de) Tetrahydrochinolinderivate als eaa antagonisten
DE59813430D1 (de) Perylenhydrazidimide als Carbonylderivatisierungsreagenzien
ATE240954T1 (de) Oxazolidinone als 5-ht2a-antagonisten
DE69812721T2 (de) Metallocorrinoide als biologisch kompatible pharmakologische mittel
DE59814330D1 (de) Heterocyclisch substituierte 4-benzoyl-pyrazole als herbizide
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
DE59708403D1 (de) Dämpfungsring
ATE232869T1 (de) Tricyclische delta3-piperidine als alpha2- antagonisten
ID18332A (id) Kain lap sekali pakai buang
DK0829393T3 (da) Brystningsliste
DE69801227D1 (de) Makrocyclische moschusmischungen
DE69617010D1 (de) Isazole derivate als fibrinogen-rezeptor-antagonisten
ID26508A (id) Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin
DE69714019D1 (de) 1,4-dihydropyridin-verbindungen als bradykinin-antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0906294

Country of ref document: EP

REN Ceased due to non-payment of the annual fee